editorw
read
great
interest
report
ackerson
et
al
morbid
mortal
rate
associ
respiratori
syncyti
viru
rsv
compar
influenza
viru
infect
older
adult
conclud
rsv
may
result
higher
morbid
mortal
rate
among
older
hospit
adult
influenza
viru
result
import
step
recogn
impact
rsv
across
whole
patient
popul
histor
attent
paid
rsv
infect
infant
moder
sever
immunocompromis
less
infect
popul
describ
ackerson
et
al
name
adult
year
old
unlik
previou
report
compar
hospit
rsv
influenza
viru
infect
author
found
higher
incid
hospit
last
day
rsv
cohort
influenza
viru
cohort
suggest
may
reflect
increas
use
recent
year
antivir
direct
influenza
viru
rsv
report
rsvinfect
influenza
virusinfect
individu
receiv
antivir
therapi
hospit
period
receiv
oseltamivir
even
though
oseltamivir
activ
rsv
inhal
ribavirin
palivizumab
current
regist
treatment
option
rsv
addit
support
care
howev
inhal
ribavirin
rare
use
nonimmunocompromis
adult
limit
evid
efficaci
price
occup
risk
healthcar
worker
expos
ribavirin
aerosol
vaccin
new
antivir
test
yet
avail
daili
practic
age
popul
howev
may
benefit
use
oral
ribavirin
describ
set
hematopoiet
stem
cell
lung
transplant
although
evid
random
control
trial
lack
ribavirin
treatment
may
benefici
effect
reduc
morbid
mortal
rate
improv
recoveri
pulmonari
function
rsv
infect
transplant
recipi
shown
elsewher
oral
ribavirin
may
inferior
inhal
therapi
popul
may
provid
good
afford
treatment
option
whether
data
also
appli
popul
older
adult
remain
confirm
absenc
evid
efficaci
oral
ribavirin
elderli
person
combin
widespread
incid
detriment
effect
rsv
infect
popul
shown
ackerson
et
al
other
underlin
need
welldesign
random
control
trial
determin
benefit
short
cours
oral
ribavirin
rsv
elderli
patient
analog
current
use
oseltamivir
influenza
viru
especi
import
light
upcom
probabl
expens
new
antivir
ribavirin
could
consid
activ
compar
furthermor
consid
high
incid
avail
quick
diagnost
method
rsv
deem
studi
need
also
certainli
feasibl
potenti
conflict
interest
author
report
potenti
conflict
author
submit
icmj
form
disclosur
potenti
conflict
interest
conflict
editor
consid
relev
content
manuscript
disclos
